ArticleCancer research communications2025

Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors.

Benedito A Carneiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.